Skip to content

DMAC

DiaMedica Therapeutics Inc.

NASDAQ · Healthcare · Biotechnology · US

$6.85
+0.00%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
P/E 2026E
P/E 2027E
P/E 2028E
P/S forward
13.68x

Trailing multiples

Trailing twelve months

P/E TTM
PEG TTM
Price / book
9.64x
Price / sales
Price / cash flow
-11.70x

Enterprise value

Enterprise value
$326.1M
EV / sales
EV / EBITDA
-8.79x
EV / EBIT
-8.39x
Market cap
$369.4M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026